Goldman Sachs’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,000
| Closed | -$1.98M | – | 6222 |
|
|
2024
Q4 | $1.98M | Buy |
+15,000
| New | +$2.11M | ﹤0.01% | 4286 |
|
|
2024
Q3 | – | Sell |
-25,000
| Closed | -$3.43M | – | 5946 |
|
|
2024
Q2 | $3.43M | Buy |
25,000
+7,500
| +43% | +$1M | ﹤0.01% | 3502 |
|
|
2024
Q1 | $2.4M | Sell |
17,500
-45,000
| -72% | -$6.15M | ﹤0.01% | 3739 |
|
|
2023
Q4 | $8.49M | Buy |
62,500
+42,500
| +213% | +$5.19M | ﹤0.01% | 2679 |
|
|
2023
Q3 | $2.45M | Hold |
20,000
| – | – | ﹤0.01% | 3617 |
|
|
2023
Q2 | $2.54M | Hold |
20,000
| – | – | ﹤0.01% | 3686 |
|
|
2023
Q1 | $2.58M | Buy |
+20,000
| New | +$2.62M | ﹤0.01% | 3662 |
|
|
2022
Q1 | – | Sell |
-150,100
| Closed | -$22.9M | – | 6707 |
|
|
2021
Q4 | $22.9M | Buy |
150,100
+50,100
| +50% | +$7.76M | ﹤0.01% | 1995 |
|
|
2021
Q3 | $16.2M | Buy |
+100,000
| New | +$16.8M | ﹤0.01% | 2269 |
|
|
2021
Q1 | – | Sell |
-20,000
| Closed | -$3.03M | – | 6189 |
|
|
2020
Q4 | $3.03M | Sell |
20,000
-187,900
| -90% | -$26.9M | ﹤0.01% | 3410 |
|
|
2020
Q3 | $28.2M | Buy |
207,900
+175,600
| +544% | +$23.8M | 0.01% | 1467 |
|
|
2020
Q2 | $4.42M | Sell |
32,300
-2,200
| -6% | -$280K | ﹤0.01% | 2886 |
|
|
2020
Q1 | $3.72M | Sell |
34,500
-52,500
| -60% | -$6.04M | ﹤0.01% | 2868 |
|
|
2019
Q4 | $10.5M | Sell |
87,000
-217,000
| -71% | -$24.2M | ﹤0.01% | 2397 |
|
|
2019
Q3 | $30.2M | Sell |
304,000
-31,500
| -9% | -$3.3M | 0.01% | 1473 |
|
|
2019
Q2 | $36.6M | Buy |
335,500
+133,200
| +66% | +$14.2M | 0.01% | 1377 |
|
|
2019
Q1 | $22.6M | Buy |
202,300
+175,300
| +649% | +$19.2M | 0.01% | 1769 |
|
|
2018
Q4 | $2.6M | Sell |
27,000
-117,800
| -81% | -$12.5M | ﹤0.01% | 3364 |
|
|
2018
Q3 | $17.7M | Sell |
144,800
-8,900
| -6% | -$1.05M | ﹤0.01% | 2019 |
|
|
2018
Q2 | $16.9M | Buy |
153,700
+117,800
| +328% | +$12.6M | ﹤0.01% | 2022 |
|
|
2018
Q1 | $3.83M | Sell |
35,900
-324,100
| -90% | -$35.9M | ﹤0.01% | 3103 |
|
|
2017
Q4 | $38.4M | Sell |
360,000
-223,500
| -38% | -$23.9M | 0.01% | 1473 |
|
|
2017
Q3 | $64.9M | Sell |
583,500
-213,000
| -27% | -$22.8M | 0.02% | 1106 |
|
|
2017
Q2 | $82.3M | Sell |
796,500
-616,500
| -44% | -$60.7M | 0.02% | 899 |
|
|
2017
Q1 | $138M | Sell |
1,413,000
-470,100
| -25% | -$45M | 0.04% | 553 |
|
|
2016
Q4 | $167M | Buy |
1,883,100
+1,051,200
| +126% | +$95.7M | 0.05% | 475 |
|
|
2016
Q3 | $80.3M | Buy |
831,900
+18,300
| +2% | +$1.74M | 0.02% | 856 |
|
|
2016
Q2 | $69.8M | Sell |
813,600
-27,300
| -3% | -$2.45M | 0.02% | 883 |
|
|
2016
Q1 | $73.1M | Buy |
840,900
+308,400
| +58% | +$27.6M | 0.02% | 833 |
|
|
2015
Q4 | $60.1M | Buy |
532,500
+21,000
| +4% | +$2.28M | 0.02% | 984 |
|
|
2015
Q3 | $51.7M | Buy |
+511,500
| New | +$61.4M | 0.02% | 1027 |
|
|
2015
Q2 | – | Sell |
-360,000
| Closed | -$41.2M | – | 7332 |
|
|
2015
Q1 | $41.2M | Buy |
360,000
+232,500
| +182% | +$25.6M | 0.01% | 1230 |
|
|
2014
Q4 | $12.9M | Sell |
127,500
-322,500
| -72% | -$31.3M | ﹤0.01% | 2146 |
|
|
2014
Q3 | $41M | Buy |
450,000
+390,000
| +650% | +$34.2M | 0.01% | 1219 |
|
|
2014
Q2 | $5.14M | Sell |
60,000
-238,200
| -80% | -$18.8M | ﹤0.01% | 3013 |
|
|
2014
Q1 | $23.5M | Buy |
298,200
+277,500
| +1,341% | +$23.1M | 0.01% | 1636 |
|
|
2013
Q4 | $1.57M | Buy |
20,700
+20,100
| +3,350% | +$1.43M | ﹤0.01% | 4325 |
|
|
2013
Q3 | $42K | Sell |
600
-45,000
| -99% | -$2.95M | ﹤0.01% | 6342 |
|
|
2013
Q2 | $2.64M | Buy |
+45,600
| New | +$2.64M | ﹤0.01% | 3420 |
|
Other funds holding IBB
CB
